11 Sep 2013
United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA
SILVER SPRING, Md., Sept. 11, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug...
SILVER SPRING, Md., July 25, 2013 /PRNewswire/ --
-- Total Revenues of $280.6 million
-- Earnings per Share of $1.60 per Basic Share or $1.52 per Diluted Share
-- Earnings Before Non-Cash Charges of...
SILVER SPRING, Md., July 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2013 financial results before market open on Thursday, July 25...
SILVER SPRING, Md., April 25, 2013 /PRNewswire/ --Total Revenues of $245.1 millionEarnings per Share of $1.24 per Basic Share or $1.19 per Diluted ShareEarnings Before Non-Cash Charges of $2.76 per Basic Share, or...
SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25...
25 Mar 2013
United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
SILVER SPRING, Md., March 25, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it received a second complete response letter from the United States Food and Drug Administration...
26 Feb 2013
United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
SILVER SPRING, Md., Feb. 26, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2012."Our excellent...
SILVER SPRING, Md., Feb. 19, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2012 financial results before market open on Tuesday...
SILVER SPRING, Md., Feb. 14, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug...
SILVER SPRING, Md., Feb. 4, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional $420 million of the company's...
SILVER SPRING, Md., Nov. 1, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2012."It is certainly gratifying to see...
SILVER SPRING, Md., Oct. 25, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2012 financial results before market open on Thursday, November 1...